{"title":"抑制半胱氨酸蛋白酶会扰乱体外骨吸收和骨形成之间的拓扑关系。","authors":"Sayaka Ono, Naoki Tsuji, Tomoaki Sakamoto, Shuya Oguchi, Takashi Nakamura, Kazuto Hoshi, Atsuhiko Hikita","doi":"10.1007/s00774-023-01489-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Osteoporosis is a global health issue. Bisphosphonates that are commonly used to treat osteoporosis suppress both bone resorption and subsequent bone formation. Inhibition of cathepsin K, a cysteine proteinase secreted by osteoclasts, was reported to suppress bone resorption while preserving or increasing bone formation. Analyses of the different effects of antiresorptive reagents such as bisphosphonates and cysteine proteinase inhibitors will contribute to the understanding of the mechanisms underlying bone remodeling.</p><p><strong>Materials and methods: </strong>Our team has developed an in vitro system in which bone remodeling can be temporally observed at the cellular level by 2-photon microscopy. We used this system in the present study to examine the effects of the cysteine proteinase inhibitor E-64 and those of zoledronic acid on bone remodeling.</p><p><strong>Results: </strong>In the control group, the amount of the reduction and the increase in the matrix were correlated in each region of interest, indicating the topological and quantitative coordination of bone resorption and formation. Parameters for osteoblasts, osteoclasts, and matrix resorption/formation were also correlated. E-64 disrupted the correlation between resorption and formation by potentially inhibiting the emergence of spherical osteoblasts, which are speculated to be reversal cells in the resorption sites.</p><p><strong>Conclusion: </strong>These new findings help clarify coupling mechanisms and will contribute to the development of new drugs for osteoporosis.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"166-184"},"PeriodicalIF":2.4000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982105/pdf/","citationCount":"0","resultStr":"{\"title\":\"Inhibition of cysteine protease disturbs the topological relationship between bone resorption and formation in vitro.\",\"authors\":\"Sayaka Ono, Naoki Tsuji, Tomoaki Sakamoto, Shuya Oguchi, Takashi Nakamura, Kazuto Hoshi, Atsuhiko Hikita\",\"doi\":\"10.1007/s00774-023-01489-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Osteoporosis is a global health issue. Bisphosphonates that are commonly used to treat osteoporosis suppress both bone resorption and subsequent bone formation. Inhibition of cathepsin K, a cysteine proteinase secreted by osteoclasts, was reported to suppress bone resorption while preserving or increasing bone formation. Analyses of the different effects of antiresorptive reagents such as bisphosphonates and cysteine proteinase inhibitors will contribute to the understanding of the mechanisms underlying bone remodeling.</p><p><strong>Materials and methods: </strong>Our team has developed an in vitro system in which bone remodeling can be temporally observed at the cellular level by 2-photon microscopy. We used this system in the present study to examine the effects of the cysteine proteinase inhibitor E-64 and those of zoledronic acid on bone remodeling.</p><p><strong>Results: </strong>In the control group, the amount of the reduction and the increase in the matrix were correlated in each region of interest, indicating the topological and quantitative coordination of bone resorption and formation. Parameters for osteoblasts, osteoclasts, and matrix resorption/formation were also correlated. E-64 disrupted the correlation between resorption and formation by potentially inhibiting the emergence of spherical osteoblasts, which are speculated to be reversal cells in the resorption sites.</p><p><strong>Conclusion: </strong>These new findings help clarify coupling mechanisms and will contribute to the development of new drugs for osteoporosis.</p>\",\"PeriodicalId\":15116,\"journal\":{\"name\":\"Journal of Bone and Mineral Metabolism\",\"volume\":\" \",\"pages\":\"166-184\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982105/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Bone and Mineral Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00774-023-01489-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone and Mineral Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00774-023-01489-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
导言骨质疏松症是一个全球性的健康问题。常用于治疗骨质疏松症的双磷酸盐类药物可抑制骨吸收和随后的骨形成。据报道,抑制破骨细胞分泌的半胱氨酸蛋白酶 cathepsin K 可抑制骨吸收,同时保持或增加骨形成。分析双膦酸盐和半胱氨酸蛋白酶抑制剂等抗骨质吸收试剂的不同作用将有助于了解骨重塑的内在机制:我们的团队开发了一种体外系统,可通过双光子显微镜在细胞水平对骨重塑进行时间观察。在本研究中,我们利用该系统研究了半胱氨酸蛋白酶抑制剂 E-64 和唑来膦酸对骨重塑的影响:结果:在对照组中,每个观察区域基质的减少量和增加量都是相关的,这表明骨吸收和骨形成在拓扑和数量上是协调的。成骨细胞、破骨细胞和基质吸收/形成的参数也相互关联。E-64 可能会抑制球形成骨细胞的出现,从而破坏吸收和形成之间的相关性,据推测球形成骨细胞是吸收部位的逆转细胞:这些新发现有助于阐明耦合机制,并有助于开发治疗骨质疏松症的新药物。
Inhibition of cysteine protease disturbs the topological relationship between bone resorption and formation in vitro.
Introduction: Osteoporosis is a global health issue. Bisphosphonates that are commonly used to treat osteoporosis suppress both bone resorption and subsequent bone formation. Inhibition of cathepsin K, a cysteine proteinase secreted by osteoclasts, was reported to suppress bone resorption while preserving or increasing bone formation. Analyses of the different effects of antiresorptive reagents such as bisphosphonates and cysteine proteinase inhibitors will contribute to the understanding of the mechanisms underlying bone remodeling.
Materials and methods: Our team has developed an in vitro system in which bone remodeling can be temporally observed at the cellular level by 2-photon microscopy. We used this system in the present study to examine the effects of the cysteine proteinase inhibitor E-64 and those of zoledronic acid on bone remodeling.
Results: In the control group, the amount of the reduction and the increase in the matrix were correlated in each region of interest, indicating the topological and quantitative coordination of bone resorption and formation. Parameters for osteoblasts, osteoclasts, and matrix resorption/formation were also correlated. E-64 disrupted the correlation between resorption and formation by potentially inhibiting the emergence of spherical osteoblasts, which are speculated to be reversal cells in the resorption sites.
Conclusion: These new findings help clarify coupling mechanisms and will contribute to the development of new drugs for osteoporosis.
期刊介绍:
The Journal of Bone and Mineral Metabolism (JBMM) provides an international forum for researchers and clinicians to present and discuss topics relevant to bone, teeth, and mineral metabolism, as well as joint and musculoskeletal disorders. The journal welcomes the submission of manuscripts from any country. Membership in the society is not a prerequisite for submission. Acceptance is based on the originality, significance, and validity of the material presented. The journal is aimed at researchers and clinicians dedicated to improvements in research, development, and patient-care in the fields of bone and mineral metabolism.